Loading...
OTCMAWKNF
Market cap2mUSD
Dec 13, Last price  
0.07USD
Name

Awakn Life Sciences Corp

Chart & Performance

D1W1MN
OTCM:AWKNF chart
P/E
—
P/S
44.48
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
87k
-94.16%
0236,0371,495,34387,373
Net income
-5m
L-44.19%
-1,259,898-15,945,845-9,142,555-5,102,704
CFO
-2m
L-67.66%
-472,889-8,586,259-7,363,586-2,381,416

Profile

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
URL
https://awaknlifesciences.com/
IPO date
Jun 23, 2021
Employees
44
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFY
2024‑012023‑012022‑012021‑01
Income
Revenues
87
-94.16%
1,495
533.52%
236
 
Cost of revenue
4,014
7,637
9,849
Unusual Expense (Income)
NOPBT
(3,926)
(6,142)
(9,613)
NOPBT Margin
Operating Taxes
(509)
(526)
Tax Rate
NOPAT
(3,926)
(5,633)
(9,087)
Net income
(5,103)
-44.19%
(9,143)
-42.66%
(15,946)
1,165.65%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,656
5,972
7,820
BB yield
Debt
Debt current
387
356
Long-term debt
3,138
2,906
Deferred revenue
Other long-term liabilities
71
544
Net debt
(407)
2,974
1,639
Cash flow
Cash from operating activities
(2,381)
(7,364)
(8,586)
CAPEX
(95)
(1,707)
Cash from investing activities
(20)
(95)
(1,685)
Cash from financing activities
2,456
6,404
11,502
FCF
(621)
(3,735)
(12,351)
Balance
Cash
407
551
1,623
Long term investments
Excess cash
403
476
1,611
Stockholders' equity
(9,024)
(50)
3,023
Invested Capital
7,493
2,330
3,765
ROIC
ROCE
256.59%
EV
Common stock shares outstanding
29,068
25,203
21,962
Price
Market cap
EV
EBITDA
(3,908)
(5,538)
(9,431)
EV/EBITDA
Interest
267
205
Interest/NOPBT